D Molecular Therapeutics™, 4DMT™, Therapeutic Vector Evolution™, and the 4DMT logo are trademarks of 4DMT. All of our product candidates are in clinical or preclinical development and have not yet ...

The Joint Commission of the Empress Shōken Fund (ESF) has announced a new distribution of funds, totalling 502,578 Swiss ...